Depression, antidepressants, and bone health in older adults: A systematic review

Journal of the American Geriatrics Society

Volumn 62, Issue 8, 2014, Pages 1434-1441

  Gebara, Marie Anne ^a   Shea, Marcie L O ^a   Lipsey, Kim L ^b   Teitelbaum, Steven L ^a   Civitelli, Roberto ^a   Müller, Daniel J ^c,d   Reynolds, Charles F ^e   Mulsant, Benoit H ^c,d   Lenze, Eric J ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

antidepressants; BMD; depression; older adults

Indexed keywords

ANTIDEPRESSANTS; BMD; DEPRESSION; OLDER ADULTS;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; BONE DENSITY; DEPRESSION; HUMANS; MIDDLE AGED; OBSERVATIONAL STUDY AS TOPIC; OSTEOPOROSIS;

EID: 84906079454     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12945     Document Type: Review

References (52)

1. Olfson M, Marcus SC,. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009; 66: 848-856.
2. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60: 616-631.
3. Kvelde T, McVeigh C, Toson B, et al. Depressive symptomatology as a risk factor for falls in older people: Systematic review and meta-analysis. J Am Geriatr Soc 2013; 61: 694-706.
4. Rabenda V, Nicolet D, Beaudart C, et al. Relationship between use of antidepressants and risk of fractures: A meta-analysis. Osteoporos Int 2013; 24: 121-137.
5. Cizza G,. Major depressive disorder is a risk factor for low bone mass, central obesity, and other medical conditions. Dialogues Clin Neurosci 2011; 13: 73-87.
6. Darowski A, Chambers SA, Chambers DJ,. Antidepressants and falls in the elderly. Drugs Aging 2009; 26: 381-394.
7. Gustafsson BI, Thommesen L, Stunes AK, et al. Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 2006; 98: 139-151.
8. Bliziotes MM, Eshleman AJ, Zhang XW, et al. Neurotransmitter action in osteoblasts: Expression of a functional system for serotonin receptor activation and reuptake. Bone 2001; 29: 477-486.
9. Bliziotes MM, Eshleman AJ, Burt-Pichat B, et al. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone 2006; 39: 1313-1321.
10. Westbroek I, van der Plas A, de Rooij KE, et al. Expression of serotonin receptors in bone. J Biol Chem 2001; 276: 28961-28968.
11. Bonnet N, Bernard P, Beaupied H, et al. Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling. Toxicol Appl Pharmacol 2007; 221: 111-118.
12. Wu Q, Bencaz AF, Hentz JG, et al. Selective serotonin reuptake inhibitor treatment and risk of fractures: A meta-analysis of cohort and case-control studies. Osteoporos Int 2012; 23: 365-375.
13. Iaboni A, Flint AJ,. The complex interplay of depression and falls in older adults: A clinical review. Am J Geriatr Psychiatry 2013; 21: 484-492.
14. Schwan S, Hallberg P,. SSRIs, bone mineral density, and risk of fractures-a review. Eur Neuropsychopharmacol 2009; 19: 683-692.
15. Hill AB,. The environment and disease: Association or causation? Proc R Soc Med 1965; 58: 295-300.
16. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol 2009; 62: e1-e34.
17. Button KS, Ioannidis JP, Mokrysz C, et al. Power failure: Why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 2013; 14: 365-376.
18. Diem SJ, Blackwell TL, Stone KL, et al. Depressive symptoms and rates of bone loss at the hip in older women. J Am Geriatr Soc 2007; 55: 824-831.
19. Diem SJ, Blackwell TL, Stone KL, et al. Use of antidepressants and rates of hip bone loss in older women: The Study of Osteoporotic Fractures. Arch Intern Med 2007; 167: 1240-1245.
20. Williams LJ, Bjerkeset O, Langhammer A, et al. The association between depressive and anxiety symptoms and bone mineral density in the general population: The HUNT Study. J Affect Disord 2011; 131: 164-171.
21. Schweiger U, Deuschle M, Korner A, et al. Low lumbar bone mineral density in patients with major depression. Am J Psychiatry 1994; 151: 1691-1693.
22. Whooley MA, Kip KE, Cauley JA, et al. Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999; 159: 484-490.
23. Reginster JY, Deroisy R, Paul I, et al. Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women. Maturitas 1999; 33: 133-137.
24. Robbins J, Hirsch CH, Whitmer RA, et al. The association of bone mineral density and depression in an older population. J Am Geriatr Soc 2001; 49: 732-736.
25. Wong SY, Lau EM, Lynn H, et al. Depression and bone mineral density: Is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong). Osteoporos Int 2005; 16: 610-615.
26. Silverman SL, Shen W, Minshall ME, et al. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: Results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study. J Rheumatol 2007; 34: 140-144.
27. Whitson HE, Sanders L, Pieper CF, et al. Depressive symptomatology and fracture risk in community-dwelling older men and women. Aging Clin Exp Res 2008; 20: 585-592.
28. Erez HB, Weller A, Vaisman N, et al. The relationship of depression, anxiety and stress with low bone mineral density in post-menopausal women. Arch Osteoporos 2012; 7: 247-255.
29. Diem SJ, Harrison SL, Haney E, et al. Depressive symptoms and rates of bone loss at the hip in older men. Osteoporos Int 2013; 24: 111-119.
30. Whooley MA, Cauley JA, Zmuda JM, et al. Depressive symptoms and bone mineral density in older men. J Geriatr Psychiatry Neurol 2004; 17: 88-92.
31. Spangler L, Scholes D, Brunner RL, et al. Depressive symptoms, bone loss, and fractures in postmenopausal women. J Gen Intern Med 2008; 23: 567-574.
32. Bolton JM, Targownik LE, Leung S, et al. Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women. J Clin Psychopharmacol 2011; 31: 56-60.
33. Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med 2003; 163: 949-957.
34. Cauley JA, Fullman RL, Stone KL, et al. Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int 2005; 16: 1525-1537.
35. Haney EM, Chan BK, Diem SJ, et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 2007; 167: 1246-1251.
36. Richards JB, Papaioannou A, Adachi JD, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007; 167: 188-194.
37. NIH consensus conference. Diagnosis and treatment of depression in late life. JAMA 1992; 268: 1018-1024.
38. Diem SJ, Ruppert K, Cauley JA, et al. Rates of bone loss among women initiating antidepressant medication use in midlife. J Clin Endocrinol Metab 2013; 98: 4355-4363.
39. Wolkowitz OM, Reus VI, Mellon SH,. Of sound mind and body: Depression, disease, and accelerated aging. Dialogues Clin Neurosci 2011; 13: 25-39.
40. O'Hara R,. Stress, aging, and mental health. Am J Geriatr Psychiatry 2006; 14: 295-298.
41. Simon NM, McNamara K, Chow CW, et al. A detailed examination of cytokine abnormalities in major depressive disorder. Eur Neuropsychopharmacol 2008; 18: 230-233.
42. Anglin RE, Samaan Z, Walter SD, et al. Vitamin D deficiency and depression in adults: Systematic review and meta-analysis. Br J Psychiatry 2013; 202: 100-107.
43. Aydin H, Mutlu N, Akbas NB,. Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women. J Psychiatr Res 2011; 45: 1316-1320.
44. Shea ML, Garfield LD, Teitelbaum SL, et al. Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption. Osteoporos Int 2013; 24: 1741-1749.
45. Garfield LD, Müller DJ, Kennedy JL, et al. Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults. World J Biol Psychiatry 2013 Sep 30 [Epub ahead of print].
46. Nelson JC, Delucchi KL, Schneider LS,. Moderators of outcome in late-life depression: A patient-level meta-analysis. Am J Psychiatry 2013; 170: 651-659.
47. Reynolds CF 3rd, Dew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med 2006; 354: 1130-1138.
48. Fiske A, Wetherell JL, Gatz M,. Depression in older adults. Annu Rev Clin Psychol 2009; 5: 363-389.
49. Vandenbroucke JP,. When are observational studies as credible as randomised trials? Lancet 2004; 363: 1728-1731.
50. Ray WA,. Evaluating medication effects outside of clinical trials: New-user designs. Am J Epidemiol 2003; 158: 915-920.
51. Hicks JK, Swen JJ, Thorn CF, et al. Clinical pharmacogenetics implementation consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin Pharmacol Ther 2013; 93: 402-408.
52. Pagura J, Katz LY, Mojtabai R, et al. Antidepressant use in the absence of common mental disorders in the general population. J Clin Psychiatry 2011; 72: 494-501.